Viewing StudyNCT00363272



Ignite Creation Date: 2024-05-05 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00363272
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 2006-08-10

Brief Title: Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
Sponsor:
Organization: National Cancer Institute NCI

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 30
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: